The Accuracy of Evaluating the Response of Metastatic Lymph Nodes after Concurrent Chemoradiotherapy in Patients with Head and Neck Squamous Cell Carcinoma-Reference-Cited by-同舟云学术

The Accuracy of Evaluating the Response of Metastatic Lymph Nodes after Concurrent Chemoradiotherapy in Patients with Head and Neck Squamous Cell Carcinoma

Published:2014 Issue:7 Volume:117 Page:899-906
ISSN:0030-6622
Container-title:Nippon Jibiinkoka Gakkai Kaiho
language:en
Short-container-title:Nippon Jibiinkoka Gakkai Kaiho

Author:

Nishimura Goshi,Komatsu Masanori,Taguchi Takahide,Takahashi Masahiro,Sano Daisuke,Sakuma Naoko,Arai Yasuhiro,Takahashi Hideaki,Tanaka Yasuko,Sawakuma Kae,Oridate Nobuhiko

Publisher

Oto-Rhino-Laryngological Society of Japan, Inc.

Subject

Otorhinolaryngology

Reference31 articles.

1. 1) Forastiere AA, Maor M, Weber RS, et al: Long-term results of Intergroup RTOG 91-11: a phase III trial to preserve the larynx-induction cisplatin/5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy [abstract]. J Clin Oncol 2006; 24: 18s. Abstract 5517.

2. 2) Domange C, Hill C, Lefebvre JL, et al: Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tere et du Cou (GETTEC). Br J Cancer 2000; 83: 1594-1598.

3. 3) Brizel DM, Albers ME, Fisher SR, et al: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998; 338: 1798-1804.

4. 4) Budach V, Stuschke M, Budach W, et al: Hyperfractionated accelerated chemoradiation with concurrecnt fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. J Clin Oncol 2005; 23: 1125-1135.

5. 5) Jermic B, Shibamoto Y, Milicic B, et al: Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol 2000; 18: 1458-1464.